Marksans Pharma Ltd. — Board/Management Information 2021

Aug 11, 2021

Date: 11" August, 2021

Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Scrip Code: 524404 Symbol: MARKSANS

BSE Limited National Stock Exchange of India Limited Mumbai - 400001. Bandra (East), Mumbai - 400051.

Sub: Outcome of Board Meeting

Dear Sir,

This is to inform you that the Board of Directors at its meeting held today i.e. 11" August, 2021 has approved the following:

• 1. The Twenty Ninth (29th) Annual General Meeting (AGM) of the Members of Marksans Pharma Limited will be held on Thursday, 23rd September, 2021 at 09:00 a.m. through video conferencing / other audio visual means (VC) facility. The Annual Report for 2020-21, including the AGM Notice which contains the e-voting process and manner of attending the AGM through VC, will be sent only through electronic mode to those Members whose email addresses are registered with the Company/Depository in due course.
• Re-appointment of Mr. Varddhman Vikramaditya Jain (DIN: 08338573) as a Wholetime Director in the category of Professional Director designated as Executive Director of the Company for a further period of Three (3) years with effect from 24" January, 2022, subject to the approval of the shareholders in the ensuing AGM. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015 along with the brief profile is given in Annexure A to this letter.
• Appointment of Mr. Sunny Sharma (DIN: 02267273) as an Additional Director in the category of Non-Executive Director with effect from 11" August, 2021. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015 along with the brief profile is given in Annexure B to this letter.

You are requested to note the above in your records.

Thanking You.

Yours faithfully, For Marksans Pharma Limited

Howhbe

Harshavardhan Panigrahi Company Secretary

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 « Tel.: +91 22 4001 2000 * E-mail: info@marksanspharma.com www.marksanspharma.com

"Na Annexure A

gq}
	Marksans Pharma Ltd.
"Na	Annexure A
Name of the Director	Mr. Varddhman Vikramaditya Jain
DIN" Reason change	08338573 Re-appointment of Mr. Varddhman Vikramaditya Jain (DIN:
removal for viz. appointment, resignation, death or-otherwise	08338573) Whole-time category Director of the as a in Professional Director designated as Executive Director of the Company for a further period of Three (3) years with effect from 24" January, 2022.
appointment Date of / applicable) & (as ion of appointment term	Period of Three (3) years with effect from 24" January, 2022 to 23 January, 2025 (both days inclusive). He would be liable to retire by rotation.
Brief profile	Varddhman Vikramaditya Pharm Mr. M. Jain is (Pharmaceuticals). He is a Pharmaceutical professional with background who worked technical with various has multinational organizations. He is specialized in the area of manufacturing, quality R&D, compliance & regulatory affairs both for API and finished dosage form manufacturing. In a career span of 26 Years, Mr. Jain has successfully handled several regulatory inspection including USFDA, UKMHRA, WHO PMDA good sound Japan leadership and with and knowledge. He has organizations very given technical the sound systems which are capable of standing up to very tough regulatory inspections of recent years.
Disclosure relationships of between directors (in case of appointment of a director)	Mr. Varddhman Vikramaditya Jain is not related inter-se to any other Director of the Company.
Information required as _ BSE pursuant Circular to LIST/ COMP/ with ref. no. 14/ 2018-19 and the National Stock Exchange of India Ltd CML/ NSE/ with no. ref. 2018/ dated June, 20th 24, 2018	Varddhman Vikramaditya debarred from Mr. Jain not is holding the office of director by virtue of any SEBI order or any other such authority.

Houle

CIN; L24HOMHT992PLC0g6364

| Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 » Tel.: +91 22 4001 2000 « E-mail: info@marksanspharma.com www.marksanspharma.com

Annexure B

qq
Marksans Pharma Ltd.
Annexure B
Name of the Director	Mr. Sunny Sharma
DIN	02267273
change Reason for appointment, resignation; Additional removaldeath-or-otherwise	viz. Appointment of Dr. Sunny Sharma (DIN: 02267273) as an Non-Executive Director category the of in Director.
appointment Date of / eessation applicable) & (as	1 1® August, 2021 He will hold the office only upto the next Annual General
term of appointment	Meeting of the Company.
Brief profile	Mr. Sunny Sharma is an M.B.A. from the Indian Institute of Management, Bangalore M.B.B.S. from and Christian an Sharma was with Medical College, Ludhiana. Mr. Investor Growth Capital (IGC), the investment arm of Investor AB in North America, and before that with Easton Capital in New Sharma worked York. Mr. Earlier career, the his in in healthcare investment banking group of Lehman Brothers in London.
Disclosure relationships of between directors (in case of	Sunny Sharma Mr. related any other not inter-se to is Director of the Company.
appointment of a director)
Information required as BSE pursuant Circular	Mr. Sunny Sharma is not debarred from holding the office of SEBI
to COMP/ LIST/ with no. ref.	director of any order any such by virtue other or authority.
14/ 2018-19 and the National
Stock Exchange of India Ltd
CML/ NSE/ with no. ref. 2018/ dated 20th June,
24, 2018

Luk she

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 « Tel.: +91 22 4001 2000 * E-mail: info@marksanspharma.com www.marksanspharma.com